FDA Drug Development Meetings May Be Better Model For Future CMS Patient-Listening Sessions

 
• By Ramsey Baghdadi
drugs_coming_out_of_ear
CMS got an earful on drug pricing. Can they make it meaningful next time? • Source: Shutterstock

More from Pricing Debate

More from Market Access